Direct health care costs of patients with type 2 diabetes within a privately insured employed population, 2000 and 2005

Journal of Occupational and Environmental Medicine

Volumn 51, Issue 12, 2009, Pages 1460-1465

  Durden, Emily D ^a   Alemayehu, Berhanu ^c   Bouchard, Jonathan R ^b   Chu, Bong Chul ^a   Aagren, Mark ^b  

^a THOMSON REUTERS   (United Kingdom)

^b NOVO NORDISK INC   (United States)

^c ASTRAZENECA   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CONTROLLED STUDY; DIABETIC PATIENT; ECONOMIC ASPECT; FEMALE; HEALTH CARE COST; HEALTH CARE PLANNING; HEALTH INSURANCE; HUMAN; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; SELF CONCEPT;

EID: 74549163562     PISSN: 10762752     EISSN: None     Source Type: Journal    
DOI: 10.1097/JOM.0b013e3181c2bb31     Document Type: Article

References (17)

1. Wild S, Roglic G, Greeg A, Sicree R, King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care. 2004;27: 1047-1053.
2. American Diabetes Association. Economic costs of diabetes in the U. S in 2007. Diabetes Care. 2008;31:596-615.
3. Hogan P, Dall T, Nikolov P. Economic costs of diabetes in the US in 2002. Diabetes Care. 2003;26:917-932.
4. Selby JV, Ray GT, Zhang D, Colby CJ. Excess costs of medical care for patients with diabetes in a managed care population. Diabetes Care. 1997;20:1396-1402.
5. Brown JB, Nichols GA, Glauber HS, Bakst AW. Type 2 diabetes: incremental medical care costs during the first 8 years after diagnosis. Diabetes Care. 1999;22: 1116-1124.
6. Goetzel RZ, Hawkins K, Ozminkowski RJ, Wang S. The health and productivity cost burden of the "top 10" physical and mental health conditions affecting six large U.S. employers in 1999. J Occup Environ Med. 2003;45:5-14.
7. Ramsey S, Summers KS, Leong SA, Birnbaum HG, Kemner JE, Greenberg P. Productivity and medical costs of diabetes in a large employer population. Diabetes Care. 2002;25:23-29.
8. Crown WH, Finkelstein S, Berndt FR et al. The impact of treatment-resistant depression on health care utilization and costs. J Clin Psychol. 2002;63:963-971.
9. Durden E, Ben Joseph R, Huse D, Chu BC. The economic costs of obesity to self-insured employers. J Occup Environ Med. 2008;50:991-997.
10. Schulman K, Kehles J. Economic burden of metastatic bone disease in the U.S. Cancer. 2007;109:2334-2342.
11. D'Agostino RB. Tutorial in biostatistics: propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group. Stat Med. 1998;17:2265-2281.
12. Charlson ME, Pompei P, Ales KL, McKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1997;40:373-383.
13. D'Hoore W, Bouckaert A, Tilquin C. Practical considerations on the use of the Charlson comorbidity index with administrative data bases. J Clin Epidemiol. 1996;49:1429-1433.
14. Ho DE, Imai K, King G, Stuart EA. Matching as nonparametric preprocessing for reducing model dependence in parametric causal inference. Available at: http://gking.harvard.edu/files/matchp.pdf. Accessed July 29, 2007.
15. United States Department of Labor, Bureau of Labor Statistics. How BLS measures price change for medical care services in the consumer price index. Available at: http://www.bls.gov/cpi/ cpifact4.htm. Accessed August 6, 2009.
16. Burton WN, Conti DJ, Chen CY, Schultz AB, Edington DW. The role of health risk factors and disease on worker productivity. J Occup Environ Med. 1999; 41:863-877.
17. Goetzel RZ, Long SR, Ozminkowski RJ, Hawkins K, Wang S, Lynch W. Health, absence, disability, and presenteeism cost estimates of certain physical and mental health conditions affecting U.S. employers. J Occup Environ Med. 2004;46:398-412.